Menu

Crowdsourcing Consensus on the Utilisation of Antiplatelet Therapy in NSTE-ACS

Join the Crowd

Join your colleagues from across the globe to influence the way in which NSTE-ACS patients are managed post-PCI.

Register Now

Overview

On behalf of the International Society of Cardiovascular Pharmacotherapy (ISCP) and Radcliffe Medical Education, thank you for your interest in taking part in this innovative crowdsourcing project, made possible with an unrestricted educational grant from AstraZeneca.

You will appreciate the important role clinical guidelines play in the practice of medicine. However, they are often outdated in relation to the latest data and empirical evidence. To address this, we are taking a novel crowdsourcing approach to pool the insight and practices of cardiologists from across the globe and will distil the prevailing beliefs and practices in a consensus statement, which we are aiming to publish in a peer reviewed journal in early 2021. The specific area of focus is on the use of monotherapy and DAPT in NSTE-ACS patients at high bleeding risk.

Based upon critical emerging data, the ISCP, in partnership with Radcliffe Medical Education, proposes an innovative crowdsourcing methodology, to create and publish a sound practice-based consensus on the treatment of high bleeding risk NSTE-ACS patients, following PCI.

To help shape this we are looking to recruit thought-leader cardiologists and other prescribers from across the globe to complete this survey. Interested participants should:

  • currently manage ACS patients
  • be able to prescribe antiplatelet therapy
  • have an understanding of ACS/antiplatelet literature

By registering to take part in this survey, you will be joining your colleagues from across the globe, to influence the way in which NSTE-ACS patients are managed post-PCI.

All respondents who complete the survey will be cited as collaborators in the publication.

Register Now



If you have colleagues also prescribing in the ACS population who you consider to have a good understanding of ACS/antiplatelet literature and whose opinion you regard as valuable, and whom you think would be interested in taking part in this research project please click here.

Invite colleagues

Steering Committee

To execute this exciting project, the Steering Committee of leading, global experts in ACS, alongside the valuable input of the crowd, will develop practice-based consensus and high-quality educational material for global dissemination.


Professor Juan Carlos Kaski – Chair

Professor of Cardiovascular Science at St George’s, University of London (SGUL), Honorary Consultant Cardiologist at St George’s Hospital, NHS Trust, London, UK and Director of the Cardiovascular and Cell Sciences Research Institute at SGUL. Immediate Past-President of ISCP (International Society of Cardiovascular Pharmacotherapy)

Professor Deepak Bhatt – Co-Chair

Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center, Professor of Medicine, Harvard Medical School

Dr Mirvat Alasnag

Director Catheterization Laboratory, King Fahd Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia, SCAI International Ambassador, ACC Interventional Leadership Council

Professor Felicita Andreotti

Professor of Cardiovascular Medicine, Institute of Cardiology, Catholic University Medical School, Rome, Italy

Professor Dominick J. Angiolillo

Professor of Medicine, Director, Cardiovascular Research, Program Director, Interventional Cardiology Fellowship, University of Florida College of Medicine

Professor Albert Ferro

Professor of Cardiovascular Clinical Pharmacology, King’s College London, London, UK

Professor Diana Gorog

Consultant Cardiologist, East and North Hertfordshire NHS Trust & Professor of Cardiovascular Medicine, University of Hertfordshire, UK

Dr Alberto J. Lorenzatti

President of the Argentine Federation of Cardiology, Co-Director, DAMIC Medical Institute / Rusculleda Foundation for Research in Medicine, Argentina

Professor Mamas Mamas

Professor of Cardiology, Keele University, UK

Professor John McNeil

Head of Department of Epidemiology and Preventive Medicine, Head of School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

Professor José C. Nicolau

Professor of University of Sao Paulo, Brazil & Director of Acute Coronary Diseases Unit, Heart Institute (InCor)

Professor Philippe Gabriel Steg

Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France

Professor Juan Tamargo

Professor of Pharmacology at the Faculty of Medicine of the Complutense University of Madrid, Madrid, Spain

Associate Professor Doreen Tan

Associate Professor, Clinical & Pharmacy Practice, Cardiology Specialist Pharmacist, Department of Pharmacy, National University of Singapore

Register Now

Pre-Reading Materials

As we will be asking for your input on a number of existing clinical trials and guidelines during the survey, you may find it helpful to familiarise yourself with the following publications. Algorithms and passages from the relevant guidelines will be accessible at specific points throughout the survey.

Clinical guidelines:

i.
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Coronary-Syndromes-ACS-in-patients-presenting-without-persistent-ST-segm

ACCESS CONTENT

ii.
2011 American College of Cardiology Foundation/American Heart Association/The Society for Cardiovascular Angiography and Interventions (ACCF/AHA/SCAI) Guideline
Available at: https://www.ahajournals.org/doi/10.1161/CIR.0b013e31823ba622

ACCESS CONTENT

iii.
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Available at: https://www.onlinejacc.org/content/68/10/1082

ACCESS CONTENT

Register Now For Free